UB-VV200

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NameUB-VV200

Drug Alias NameUB VV200 + TumorTag cocktail(Umoja BioPharma Inc)UB VV200 with TumorTag cocktail(Umoja BioPharma Inc)UB-VV200UBVV200

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vectorCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy > In vivo CAR-T therapyCell and gene therapy > Cell therapy > In vivo cell therapy > In vivo CAR-T therapy

Mechanisms of ActionGPI-anchored folate receptors inhibitors

TargetsGPI-anchored folate receptors

Therapy Area/IndicationsSolid tumoursGenital Neoplasms, Female

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUmoja BioPharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesUmoja BioPharma Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursGenital Neoplasms, Female

Inactive IndicationsN/A

Other Information

ATC CodeN/A